Filter
620
Text search:
National
Centre
for
Disease
Control,
India
Featured
Recommendations
73
New Publications
160
Language
Document type
No document type
334
Studies & Reports
123
Guidelines
82
Manuals
39
Strategic & Response Plan
18
Training Material
9
Situation Updates
6
Fact sheets
6
Resource Platforms
2
Infographics
1
Countries / Regions
India
99
Global
31
Nepal
14
Asia
11
South Africa
10
South–East Asia Region
10
Myanmar / Burma
8
Syria
7
Bangladesh
6
Nigeria
5
Kenya
5
Malawi
5
Sierra Leone
4
Liberia
4
Afghanistan
4
Tanzania
4
Latin America and the Carribbean
4
Western and Central Europe
4
Russia
4
Pakistan
3
Ukraine
3
Yemen
3
Middle East and North Africa
3
Africa
3
Eastern Europe
3
Guinea
2
Ethiopia
2
Ghana
2
Zimbabwe
2
Haiti
2
Philippines
2
Somalia
2
South Sudan
2
Brazil
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Tajikistan
2
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Iraq
1
Lebanon
1
Zambia
1
Thailand
1
China
1
Rwanda
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Central African Republic
1
Colombia
1
Ecuador
1
Libya
1
Mexico
1
East and Southern Africa
1
West and Central Africa
1
Other region
1
Bhutan
1
Palestine
1
Albania
1
Armenia
1
Mongolia
1
Moldova
1
Kazakhstan
1
North America
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
168
Clinical Guidelines
82
Public Health
43
Key Resources
37
Women & Child Health
36
Pharmacy & Technologies
8
Capacity Building
5
Toolboxes
HIV
62
TB
56
Mental Health
50
COVID-19
47
AMR
30
NTDs
24
Planetary Health
20
Disability
18
Caregiver
17
NCDs
17
Global Health Education
16
Rapid Response
10
Refugee
10
Polio
9
Pharmacy
9
Ebola & Marburg
8
Conflict
7
Health Financing Toolbox
7
Natural Hazards
6
Cholera
4
Malaria
4
2.0 Rapid Response
4
Specific Hazards
3
Zika
2
Social Ethics
2
Public Health Action
vol 5 no 3 published 21 september 2015
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones
...
Standard Treatment Guideline
In resource restriced countries
Joining efforts to control two trelated global epidemics.
Towards the Peoples Health Assembly Book -5
Accessed Febr. 6, 2020
Towards the Peoples Health Assembly Book -4
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are respo
...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p
...
WHO/CDS/TB/99.272
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antib
...